Ben Johnson was named Head Coach of the Chicago Bears on January 21, 2025, becoming the 18th full-time Head Coach in the franchise's history. In his first season as Head Coach of the Bears, Johnson ...

While the Philadelphia Eagles are undergoing changes this offseason, they will be retaining a key part of their team in perennial All-Pro right tackle Lane Johnson, who has told the Philadelphia ...

Feb 19 (Reuters) - Johnson & Johnson is preparing a potential sale of the orthopedics unit that it has ‌been planning to separate, with big buyout firms already ‌circling, Bloomberg News reported on ...

Bayer BAYGn.DE sued Johnson & Johnson JNJ.N on Monday, accusing the drugmaker of falsely advertising a rival multibillion-dollar drug to treat prostate cancer. In a complaint filed in Manhattan ...

NEW YORK, Feb 23 (Reuters) - Bayer (BAYGn.DE), opens new tab sued Johnson & Johnson (JNJ.N), opens new tab on Monday, accusing the drugmaker of falsely advertising that its rival multibillion-dollar ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The new Johnson & Johnson plant ...

Pennsylvania’s life sciences sector took another step forward Wednesday when a pharmaceutical giant debuted plans for a cell and gene therapy manufacturing facility in suburban Philadelphia. Johnson & ...

LOWER GWYNEDD TWP., Pa. (WPVI) -- Johnson & Johnson is investing more than $1 billion to build a new cell therapy plant in Montgomery County. The new investment will bring more than 500 jobs over the ...

A global health care company says that it will begin making state of the art cancer fighting medicines in our area. It's a move that Pennsylvania Gov. Josh Shapiro says won't just save lives but will ...

A $1B-plus Lower Gwynedd cell therapy site advances supply-chain resilience by localizing advanced medicine production for US demand while linking discovery capabilities to scalable manufacturing. The ...

Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma M&A announcement today. The $132-per-share agreement comes a few months ...